COVID-19 Impact on Global Acne Vulgaris Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 125 pages | ID: C57F2299A647EN
QYResearch

Abstracts

This report focuses on the global Acne Vulgaris Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acne Vulgaris Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Common Pharma Inc
• Cutanea Life Sciences Inc
• Dermira Inc
• ELORAC Inc
• Ensol Biosciences Inc
• Foamix Pharmaceuticals Ltd
• Galderma SA
• GlaxoSmithKline Plc
• Helix BioMedix Inc
• Hovione FarmaCiencia SA
• Lee's Pharmaceutical Holdings Ltd
• LEO Pharma A/S
• Novabiotics Ltd
• Novan Inc
• Novartis AG
• Paratek Pharmaceuticals Inc
• Pfizer Inc
• Phosphagenics Ltd

Market segment by Type, the product can be split into

• CB-0601
• CJM-112
• CLS-007
• Dapsone
• DFD-10
• DLX-2323
• Others

Market segment by Application, split into

• Clinic
• Hospital
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Acne Vulgaris Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Acne Vulgaris Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Acne Vulgaris Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acne Vulgaris Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Acne Vulgaris Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 CB-0601
  1.4.3 CJM-112
  1.4.4 CLS-007
  1.4.5 Dapsone
  1.4.6 DFD-10
  1.4.7 DLX-2323
  1.4.8 Others
1.5 Market by Application
  1.5.1 Global Acne Vulgaris Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Clinic
  1.5.3 Hospital
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Acne Vulgaris Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Acne Vulgaris Treatment Industry
    1.6.1.1 Acne Vulgaris Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Acne Vulgaris Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Acne Vulgaris Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Acne Vulgaris Treatment Market Perspective (2015-2026)
2.2 Acne Vulgaris Treatment Growth Trends by Regions
  2.2.1 Acne Vulgaris Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Acne Vulgaris Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Acne Vulgaris Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Acne Vulgaris Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Acne Vulgaris Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Acne Vulgaris Treatment Players by Market Size
  3.1.1 Global Top Acne Vulgaris Treatment Players by Revenue (2015-2020)
  3.1.2 Global Acne Vulgaris Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acne Vulgaris Treatment Market Concentration Ratio
  3.2.1 Global Acne Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Treatment Revenue in 2019
3.3 Acne Vulgaris Treatment Key Players Head office and Area Served
3.4 Key Players Acne Vulgaris Treatment Product Solution and Service
3.5 Date of Enter into Acne Vulgaris Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Acne Vulgaris Treatment Historic Market Size by Type (2015-2020)
4.2 Global Acne Vulgaris Treatment Forecasted Market Size by Type (2021-2026)

5 ACNE VULGARIS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Acne Vulgaris Treatment Market Size by Application (2015-2020)
5.2 Global Acne Vulgaris Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Acne Vulgaris Treatment Market Size (2015-2020)
6.2 Acne Vulgaris Treatment Key Players in North America (2019-2020)
6.3 North America Acne Vulgaris Treatment Market Size by Type (2015-2020)
6.4 North America Acne Vulgaris Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Acne Vulgaris Treatment Market Size (2015-2020)
7.2 Acne Vulgaris Treatment Key Players in Europe (2019-2020)
7.3 Europe Acne Vulgaris Treatment Market Size by Type (2015-2020)
7.4 Europe Acne Vulgaris Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Acne Vulgaris Treatment Market Size (2015-2020)
8.2 Acne Vulgaris Treatment Key Players in China (2019-2020)
8.3 China Acne Vulgaris Treatment Market Size by Type (2015-2020)
8.4 China Acne Vulgaris Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Acne Vulgaris Treatment Market Size (2015-2020)
9.2 Acne Vulgaris Treatment Key Players in Japan (2019-2020)
9.3 Japan Acne Vulgaris Treatment Market Size by Type (2015-2020)
9.4 Japan Acne Vulgaris Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Acne Vulgaris Treatment Market Size (2015-2020)
10.2 Acne Vulgaris Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acne Vulgaris Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Acne Vulgaris Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Acne Vulgaris Treatment Market Size (2015-2020)
11.2 Acne Vulgaris Treatment Key Players in India (2019-2020)
11.3 India Acne Vulgaris Treatment Market Size by Type (2015-2020)
11.4 India Acne Vulgaris Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Acne Vulgaris Treatment Market Size (2015-2020)
12.2 Acne Vulgaris Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Acne Vulgaris Treatment Market Size by Type (2015-2020)
12.4 Central & South America Acne Vulgaris Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Common Pharma Inc
  13.1.1 Common Pharma Inc Company Details
  13.1.2 Common Pharma Inc Business Overview and Its Total Revenue
  13.1.3 Common Pharma Inc Acne Vulgaris Treatment Introduction
  13.1.4 Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2015-2020))
  13.1.5 Common Pharma Inc Recent Development
13.2 Cutanea Life Sciences Inc
  13.2.1 Cutanea Life Sciences Inc Company Details
  13.2.2 Cutanea Life Sciences Inc Business Overview and Its Total Revenue
  13.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Introduction
  13.2.4 Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  13.2.5 Cutanea Life Sciences Inc Recent Development
13.3 Dermira Inc
  13.3.1 Dermira Inc Company Details
  13.3.2 Dermira Inc Business Overview and Its Total Revenue
  13.3.3 Dermira Inc Acne Vulgaris Treatment Introduction
  13.3.4 Dermira Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  13.3.5 Dermira Inc Recent Development
13.4 ELORAC Inc
  13.4.1 ELORAC Inc Company Details
  13.4.2 ELORAC Inc Business Overview and Its Total Revenue
  13.4.3 ELORAC Inc Acne Vulgaris Treatment Introduction
  13.4.4 ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  13.4.5 ELORAC Inc Recent Development
13.5 Ensol Biosciences Inc
  13.5.1 Ensol Biosciences Inc Company Details
  13.5.2 Ensol Biosciences Inc Business Overview and Its Total Revenue
  13.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Introduction
  13.5.4 Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  13.5.5 Ensol Biosciences Inc Recent Development
13.6 Foamix Pharmaceuticals Ltd
  13.6.1 Foamix Pharmaceuticals Ltd Company Details
  13.6.2 Foamix Pharmaceuticals Ltd Business Overview and Its Total Revenue
  13.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Introduction
  13.6.4 Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  13.6.5 Foamix Pharmaceuticals Ltd Recent Development
13.7 Galderma SA
  13.7.1 Galderma SA Company Details
  13.7.2 Galderma SA Business Overview and Its Total Revenue
  13.7.3 Galderma SA Acne Vulgaris Treatment Introduction
  13.7.4 Galderma SA Revenue in Acne Vulgaris Treatment Business (2015-2020)
  13.7.5 Galderma SA Recent Development
13.8 GlaxoSmithKline Plc
  13.8.1 GlaxoSmithKline Plc Company Details
  13.8.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
  13.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Introduction
  13.8.4 GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  13.8.5 GlaxoSmithKline Plc Recent Development
13.9 Helix BioMedix Inc
  13.9.1 Helix BioMedix Inc Company Details
  13.9.2 Helix BioMedix Inc Business Overview and Its Total Revenue
  13.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Introduction
  13.9.4 Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  13.9.5 Helix BioMedix Inc Recent Development
13.10 Hovione FarmaCiencia SA
  13.10.1 Hovione FarmaCiencia SA Company Details
  13.10.2 Hovione FarmaCiencia SA Business Overview and Its Total Revenue
  13.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Introduction
  13.10.4 Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2015-2020)
  13.10.5 Hovione FarmaCiencia SA Recent Development
13.11 Lee's Pharmaceutical Holdings Ltd
  10.11.1 Lee's Pharmaceutical Holdings Ltd Company Details
  10.11.2 Lee's Pharmaceutical Holdings Ltd Business Overview and Its Total Revenue
  10.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Introduction
  10.11.4 Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  10.11.5 Lee's Pharmaceutical Holdings Ltd Recent Development
13.12 LEO Pharma A/S
  10.12.1 LEO Pharma A/S Company Details
  10.12.2 LEO Pharma A/S Business Overview and Its Total Revenue
  10.12.3 LEO Pharma A/S Acne Vulgaris Treatment Introduction
  10.12.4 LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2015-2020)
  10.12.5 LEO Pharma A/S Recent Development
13.13 Novabiotics Ltd
  10.13.1 Novabiotics Ltd Company Details
  10.13.2 Novabiotics Ltd Business Overview and Its Total Revenue
  10.13.3 Novabiotics Ltd Acne Vulgaris Treatment Introduction
  10.13.4 Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  10.13.5 Novabiotics Ltd Recent Development
13.14 Novan Inc
  10.14.1 Novan Inc Company Details
  10.14.2 Novan Inc Business Overview and Its Total Revenue
  10.14.3 Novan Inc Acne Vulgaris Treatment Introduction
  10.14.4 Novan Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  10.14.5 Novan Inc Recent Development
13.15 Novartis AG
  10.15.1 Novartis AG Company Details
  10.15.2 Novartis AG Business Overview and Its Total Revenue
  10.15.3 Novartis AG Acne Vulgaris Treatment Introduction
  10.15.4 Novartis AG Revenue in Acne Vulgaris Treatment Business (2015-2020)
  10.15.5 Novartis AG Recent Development
13.16 Paratek Pharmaceuticals Inc
  10.16.1 Paratek Pharmaceuticals Inc Company Details
  10.16.2 Paratek Pharmaceuticals Inc Business Overview and Its Total Revenue
  10.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Introduction
  10.16.4 Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  10.16.5 Paratek Pharmaceuticals Inc Recent Development
13.17 Pfizer Inc
  10.17.1 Pfizer Inc Company Details
  10.17.2 Pfizer Inc Business Overview and Its Total Revenue
  10.17.3 Pfizer Inc Acne Vulgaris Treatment Introduction
  10.17.4 Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  10.17.5 Pfizer Inc Recent Development
13.18 Phosphagenics Ltd
  10.18.1 Phosphagenics Ltd Company Details
  10.18.2 Phosphagenics Ltd Business Overview and Its Total Revenue
  10.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Introduction
  10.18.4 Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  10.18.5 Phosphagenics Ltd Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Acne Vulgaris Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Acne Vulgaris Treatment Revenue
Table 3. Ranking of Global Top Acne Vulgaris Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acne Vulgaris Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CB-0601
Table 6. Key Players of CJM-112
Table 7. Key Players of CLS-007
Table 8. Key Players of Dapsone
Table 9. Key Players of DFD-10
Table 10. Key Players of DLX-2323
Table 11. Key Players of Others
Table 12. COVID-19 Impact Global Market: (Four Acne Vulgaris Treatment Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Acne Vulgaris Treatment Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Acne Vulgaris Treatment Players to Combat Covid-19 Impact
Table 17. Global Acne Vulgaris Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Acne Vulgaris Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Acne Vulgaris Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Acne Vulgaris Treatment Market Share by Regions (2015-2020)
Table 21. Global Acne Vulgaris Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Acne Vulgaris Treatment Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Acne Vulgaris Treatment Market Growth Strategy
Table 27. Main Points Interviewed from Key Acne Vulgaris Treatment Players
Table 28. Global Acne Vulgaris Treatment Revenue by Players (2015-2020) (Million US$)
Table 29. Global Acne Vulgaris Treatment Market Share by Players (2015-2020)
Table 30. Global Top Acne Vulgaris Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acne Vulgaris Treatment as of 2019)
Table 31. Global Acne Vulgaris Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Acne Vulgaris Treatment Product Solution and Service
Table 34. Date of Enter into Acne Vulgaris Treatment Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. Global Acne Vulgaris Treatment Market Size Share by Type (2015-2020)
Table 38. Global Acne Vulgaris Treatment Revenue Market Share by Type (2021-2026)
Table 39. Global Acne Vulgaris Treatment Market Size Share by Application (2015-2020)
Table 40. Global Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. Global Acne Vulgaris Treatment Market Size Share by Application (2021-2026)
Table 42. North America Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 44. North America Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. North America Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 46. North America Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. North America Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 48. Europe Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 50. Europe Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 52. Europe Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 54. China Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 55. China Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 56. China Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. China Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 58. China Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. China Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 60. Japan Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 62. Japan Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 64. Japan Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 68. Southeast Asia Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 70. Southeast Asia Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 72. India Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 73. India Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 74. India Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. India Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 76. India Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. India Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 80. Central & South America Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 82. Central & South America Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 84. Common Pharma Inc Company Details
Table 85. Common Pharma Inc Business Overview
Table 86. Common Pharma Inc Product
Table 87. Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 88. Common Pharma Inc Recent Development
Table 89. Cutanea Life Sciences Inc Company Details
Table 90. Cutanea Life Sciences Inc Business Overview
Table 91. Cutanea Life Sciences Inc Product
Table 92. Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 93. Cutanea Life Sciences Inc Recent Development
Table 94. Dermira Inc Company Details
Table 95. Dermira Inc Business Overview
Table 96. Dermira Inc Product
Table 97. Dermira Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 98. Dermira Inc Recent Development
Table 99. ELORAC Inc Company Details
Table 100. ELORAC Inc Business Overview
Table 101. ELORAC Inc Product
Table 102. ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 103. ELORAC Inc Recent Development
Table 104. Ensol Biosciences Inc Company Details
Table 105. Ensol Biosciences Inc Business Overview
Table 106. Ensol Biosciences Inc Product
Table 107. Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 108. Ensol Biosciences Inc Recent Development
Table 109. Foamix Pharmaceuticals Ltd Company Details
Table 110. Foamix Pharmaceuticals Ltd Business Overview
Table 111. Foamix Pharmaceuticals Ltd Product
Table 112. Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 113. Foamix Pharmaceuticals Ltd Recent Development
Table 114. Galderma SA Company Details
Table 115. Galderma SA Business Overview
Table 116. Galderma SA Product
Table 117. Galderma SA Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 118. Galderma SA Recent Development
Table 119. GlaxoSmithKline Plc Business Overview
Table 120. GlaxoSmithKline Plc Product
Table 121. GlaxoSmithKline Plc Company Details
Table 122. GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 123. GlaxoSmithKline Plc Recent Development
Table 124. Helix BioMedix Inc Company Details
Table 125. Helix BioMedix Inc Business Overview
Table 126. Helix BioMedix Inc Product
Table 127. Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 128. Helix BioMedix Inc Recent Development
Table 129. Hovione FarmaCiencia SA Company Details
Table 130. Hovione FarmaCiencia SA Business Overview
Table 131. Hovione FarmaCiencia SA Product
Table 132. Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 133. Hovione FarmaCiencia SA Recent Development
Table 134. Lee's Pharmaceutical Holdings Ltd Company Details
Table 135. Lee's Pharmaceutical Holdings Ltd Business Overview
Table 136. Lee's Pharmaceutical Holdings Ltd Product
Table 137. Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 138. Lee's Pharmaceutical Holdings Ltd Recent Development
Table 139. LEO Pharma A/S Company Details
Table 140. LEO Pharma A/S Business Overview
Table 141. LEO Pharma A/S Product
Table 142. LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 143. LEO Pharma A/S Recent Development
Table 144. Novabiotics Ltd Company Details
Table 145. Novabiotics Ltd Business Overview
Table 146. Novabiotics Ltd Product
Table 147. Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 148. Novabiotics Ltd Recent Development
Table 149. Novan Inc Company Details
Table 150. Novan Inc Business Overview
Table 151. Novan Inc Product
Table 152. Novan Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 153. Novan Inc Recent Development
Table 154. Novartis AG Company Details
Table 155. Novartis AG Business Overview
Table 156. Novartis AG Product
Table 157. Novartis AG Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 158. Novartis AG Recent Development
Table 159. Paratek Pharmaceuticals Inc Company Details
Table 160. Paratek Pharmaceuticals Inc Business Overview
Table 161. Paratek Pharmaceuticals Inc Product
Table 162. Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 163. Paratek Pharmaceuticals Inc Recent Development
Table 164. Pfizer Inc Company Details
Table 165. Pfizer Inc Business Overview
Table 166. Pfizer Inc Product
Table 167. Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 168. Pfizer Inc Recent Development
Table 169. Phosphagenics Ltd Company Details
Table 170. Phosphagenics Ltd Business Overview
Table 171. Phosphagenics Ltd Product
Table 172. Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 173. Phosphagenics Ltd Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Acne Vulgaris Treatment Market Share by Type: 2020 VS 2026
Figure 2. CB-0601 Features
Figure 3. CJM-112 Features
Figure 4. CLS-007 Features
Figure 5. Dapsone Features
Figure 6. DFD-10 Features
Figure 7. DLX-2323 Features
Figure 8. Others Features
Figure 9. Global Acne Vulgaris Treatment Market Share by Application: 2020 VS 2026
Figure 10. Clinic Case Studies
Figure 11. Hospital Case Studies
Figure 12. Others Case Studies
Figure 13. Acne Vulgaris Treatment Report Years Considered
Figure 14. Global Acne Vulgaris Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Acne Vulgaris Treatment Market Share by Regions: 2020 VS 2026
Figure 16. Global Acne Vulgaris Treatment Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Acne Vulgaris Treatment Market Share by Players in 2019
Figure 19. Global Top Acne Vulgaris Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acne Vulgaris Treatment as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Acne Vulgaris Treatment Revenue in 2019
Figure 21. North America Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Common Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Common Pharma Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 30. Cutanea Life Sciences Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Cutanea Life Sciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 32. Dermira Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Dermira Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 34. ELORAC Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. ELORAC Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 36. Ensol Biosciences Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Ensol Biosciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 38. Foamix Pharmaceuticals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Foamix Pharmaceuticals Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 40. Galderma SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Galderma SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 42. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. GlaxoSmithKline Plc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 44. Helix BioMedix Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Helix BioMedix Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 46. Hovione FarmaCiencia SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Hovione FarmaCiencia SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 48. Lee's Pharmaceutical Holdings Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Lee's Pharmaceutical Holdings Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 50. LEO Pharma A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. LEO Pharma A/S Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 52. Novabiotics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Novabiotics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 54. Novan Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Novan Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 56. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Novartis AG Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 58. Paratek Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Paratek Pharmaceuticals Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 60. Pfizer Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Pfizer Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 62. Phosphagenics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Phosphagenics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed